ATE258182T1 - Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocyten - Google Patents
Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocytenInfo
- Publication number
- ATE258182T1 ATE258182T1 AT00917119T AT00917119T ATE258182T1 AT E258182 T1 ATE258182 T1 AT E258182T1 AT 00917119 T AT00917119 T AT 00917119T AT 00917119 T AT00917119 T AT 00917119T AT E258182 T1 ATE258182 T1 AT E258182T1
- Authority
- AT
- Austria
- Prior art keywords
- lymphocytes
- selective inhibitors
- delta
- gamma
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4028—Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4037—Esters of poly(thio)phosphonic acids containing halogen or nitro(so) substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9904263A FR2791981B1 (fr) | 1999-04-06 | 1999-04-06 | Composes inhibant selectivement les lymphocytes tgamma9delta2, et leurs applications |
| PCT/FR2000/000837 WO2000059916A1 (fr) | 1999-04-06 | 2000-04-04 | Composes inhibitant selectivement les lymphocytes t gamma 9 delta 2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE258182T1 true ATE258182T1 (de) | 2004-02-15 |
Family
ID=9544056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00917119T ATE258182T1 (de) | 1999-04-06 | 2000-04-04 | Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocyten |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6624151B1 (de) |
| EP (1) | EP1165573B1 (de) |
| AT (1) | ATE258182T1 (de) |
| AU (1) | AU3823800A (de) |
| DE (1) | DE60007847T2 (de) |
| FR (1) | FR2791981B1 (de) |
| WO (1) | WO2000059916A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003009855A2 (de) * | 2001-07-20 | 2003-02-06 | Bioagency Ag | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen |
| FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| EP1426052B1 (de) * | 2002-12-02 | 2009-09-02 | Innate Pharma | Interleukin-2 und Gamma Delta T Zellaktivator enthaltende Zusammensetzungen und deren Verwendungen |
| WO2005054258A2 (en) * | 2003-12-02 | 2005-06-16 | Innate Pharma | New class of gamma delta t cells activators and use thereof |
| US20100291118A1 (en) * | 2003-12-02 | 2010-11-18 | Innate Pharma | Class of Gamma Delta T Cells Activators and Use Thereof |
| WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| AU2006298677A1 (en) * | 2005-10-06 | 2007-04-12 | Innate Pharma | Phosphoantigen salts of organic bases and methods for their crystallization |
| WO2008059052A1 (en) | 2006-11-17 | 2008-05-22 | Innate Pharma | Improved methods of using phosphoantigen for the treatment of cancer |
| CN109651429A (zh) * | 2017-10-11 | 2019-04-19 | 清华大学 | 高效稳定的Vγ9Vδ2 T细胞的小分子激动剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639653A (en) * | 1993-07-19 | 1997-06-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy | Method for proliferating Vγ2Vδ2 T cells |
| FR2715660A1 (fr) * | 1994-01-28 | 1995-08-04 | Centre Nat Rech Scient | Composés organo-phosphorés activateurs des lymphocytes Tgammadelta, procédé pour préparer et/ou isoler et/ou caractériser ces composés, compositions et utilisations pharmaceutiques. |
| FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
| FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
-
1999
- 1999-04-06 FR FR9904263A patent/FR2791981B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-04 AT AT00917119T patent/ATE258182T1/de not_active IP Right Cessation
- 2000-04-04 AU AU38238/00A patent/AU3823800A/en not_active Abandoned
- 2000-04-04 DE DE60007847T patent/DE60007847T2/de not_active Expired - Fee Related
- 2000-04-04 US US09/958,323 patent/US6624151B1/en not_active Expired - Fee Related
- 2000-04-04 WO PCT/FR2000/000837 patent/WO2000059916A1/fr not_active Ceased
- 2000-04-04 EP EP00917119A patent/EP1165573B1/de not_active Expired - Lifetime
-
2003
- 2003-07-03 US US10/611,852 patent/US20040006131A1/en not_active Abandoned
- 2003-07-03 US US10/612,008 patent/US20040009123A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FR2791981A1 (fr) | 2000-10-13 |
| AU3823800A (en) | 2000-10-23 |
| US6624151B1 (en) | 2003-09-23 |
| EP1165573B1 (de) | 2004-01-21 |
| US20040006131A1 (en) | 2004-01-08 |
| DE60007847T2 (de) | 2004-11-04 |
| FR2791981B1 (fr) | 2001-07-20 |
| WO2000059916A1 (fr) | 2000-10-12 |
| DE60007847D1 (de) | 2004-02-26 |
| EP1165573A1 (de) | 2002-01-02 |
| US20040009123A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1622616A4 (de) | Hemmer der akt aktivität | |
| EP1631548A4 (de) | Hemmer der akt aktivität | |
| EP1620411A4 (de) | Hemmer der akt aktivität | |
| UY27638A1 (es) | Compuesto inhibidor de la hepatitis c | |
| BR0312560A (pt) | Novas espiropiperidinas ou espiropirrolidinas tricìclicas | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| DE60041584D1 (de) | Substituierte oxoazaheterozyclische verbindungen | |
| SE9904652D0 (sv) | Novel Compounds | |
| YU65802A (sh) | Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže | |
| UY26899A1 (es) | Derivados de pirazol fusionados | |
| ATE400274T1 (de) | Hemmstoffe der akt aktivität | |
| ECSP045104A (es) | Ligandos de los receptores de los cannabinoides | |
| AR011116A1 (es) | Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene | |
| WO2001092255A3 (en) | Epothilone derivatives and methods for making and using the same | |
| EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| ATE258182T1 (de) | Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocyten | |
| EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
| DE60121587D1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| TW200505446A (en) | Inhibitor of cox | |
| ATE526323T1 (de) | Die hiv-protease hemmende verbindungen | |
| AR044175A1 (es) | Compuestos de cefemo | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| DE60110124D1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |